Association of the FDA Amendment Act with trial registration, publication, and outcome reporting

Publication of Clinical Studies Supporting FDA Premarket Approval for High-Risk Cardiovascular Devices Between 2011 and 2013

(2016) Adam T. Phillips et al.   JAMA Internal Medicine

Compliance with Results Reporting at ClinicalTrials.gov

(2015) Monique L. Anderson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012

(2015) Jennifer E Miller et al.   BMJ Open

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports

(2015) L. Chang et al.   BMJ-British Medical Journal

Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports

(2015) L. Chang et al.   BMJ-British Medical Journal

Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012

(2014) Nicholas S. Downing et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Publication of Pivotal Efficacy Trials for Novel Therapeutic Agents Approved Between 2005 and 2011

(2014) James W. Smithy et al.   JAMA Internal Medicine

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE